CAMP4 Therapeutics, a Cambridge, MA-based biotechnology company harnessing the power of RNA to restore healthy protein expression, closed a $100 million Series B funding round. The round was led by Enavate Sciences, a portfolio company created by Patient Square Capital, with participation from a large national managed care organization and …

Iris Technologies, a Silicon Scope, UT-based provider of a communication hub to simplify construction project management, raised $3.2 million in seed funding. The round was led by Resolute Ventures, with participation from AnimoVentures, Long Journey Ventures, and Grix Venture Capital. The company intends to use the funds to continue to …

Fundflo Technologies, a fintech SaaS platform, has raised an undisclosed amount of Seed funding from Ashish Kacholia of Lucky Investments. The fundraiser will help the company to invest in new technologies and come up with new offerings. Company: Fundflo Technologies Pvt. Ltd Raised: Undisclosed Round: Seed Round Funding Month: July …

BigHat Biosciences, a San Mateo, CA-bases biotechnology company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, announced that it raised a $75 million Series B funding. The round was led by Section 32, with participation from new investors Amgen Ventures, Bristol Myers Squibb, Quadrille …

SupplyPike, a Fayetteville-based supply chain SaaS company, raised $25 million in Series B funding. The fund was led by Noro-Moseley Partners and Frontier Growth invested in the four-year-old company’s Series B and investors from there will be joining SupplyPike’s board, which also includes existing investors at Blumberg Capital. The company …

Proteus Motion, an NYC-based fitness technology company, raised $8.5 million in a Series A funding round. The round was co-led by Acies Investment and HBSE Ventures with participation from Harrison & Co., Monozukuri Ventures, and 412 Ventures, as well as Blake Griffin’s Blake Griffin Enterprises, NBA Champion Matthew Dellavedova, and …

Delfi Diagnostics, Inc., a Baltimore and Palo Alto, CA-based developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, announced that it raised $225 million in Series B. This round of financing was led by DFJ Growth with participation from Eli Lilly and …